Market Notices: Market Notice 110/23– Last day of trading in DanCann Pharma A/S´s subscription option DANCAN TO 2

Press release from Companies: Correction: DanCann Pharma A/S invites to an investor presentation and Q&A session in relation to ongoing exercise period of warrants

Press release from Companies: DanCann Pharma A/S invites to an investor presentation and Q&A session in relation to ongoing exercise period of warrants

Press release from Companies: DanCann Pharma A/S: The exercise period for warrants of series TO 2 begins today

Press release from Companies: DanCann Pharma A/S: The subscription price for warrants of series TO 2 has been set

Press release from Companies: DanCann Pharma A/S styrker sit regulatoriske fokus med indstilling af life science-advokat til bestyrelsen

Press release from Companies: DanCann Pharma A/S is strengthening its regulatory focus by appointing a life science lawyer to the board of directors

Press release from Companies: NOTICE OF ANNUAL GENERAL MEETING 2023 IN DANCANN PHARMA A/S

Press release from Companies: DanCann Pharma A/S publishes Annual Report 2022

Press release from Companies: DanCann Pharma A/S has signed an exclusive contract with MYCB1 GmbH for the distribution of full-spectrum extracts based on Bedrocan International varieties

Press release from Companies: DanCann Pharma A/S has signed an exclusive contract with MYCB1 GmbH for the distribution of full-spectrum extracts based on Bedrocan International varieties

Press release from Companies: Correction: DanCann Pharma A/S is reducing its debt with current lenders through a share issue by conversion of debt at market conditions